Candriam Equities L Oncology Fund Class NH Fonds
188,48
EUR
-1,43
EUR
-0,75
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 6,56% |
| Roche Holding AG | CH0012032048 | 5,13% |
| Merck & Co Inc | US58933Y1055 | 5,11% |
| Thermo Fisher Scientific Inc | US8835561023 | 4,78% |
| Amgen Inc | US0311621009 | 4,19% |
| AstraZeneca PLC | GB0009895292 | 4,19% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,96% |
| Gilead Sciences Inc | US3755581036 | 3,93% |
| Novo Nordisk AS Class B | DK0062498333 | 3,78% |
| Siemens Healthineers AG Registered Shares | DE000SHL1006 | 3,65% |
| Sonstige | 54,73% |